Juan Cunarro
Overview
Explore the profile of Juan Cunarro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duran-Lobato M, Tovar S, Cunarro J, Ramos-Membrive R, Penuelas I, Marigo I, et al.
J Control Release
. 2024 Nov;
377:17-36.
PMID: 39547419
With the growing number of marketed biological drugs, the development of technological strategies for their oral systemic absorption, becomes increasingly important. The harsh gastrointestinal environment and low permeability of the...
2.
Pena-Leon V, Folgueira C, Barja-Fernandez S, Perez-Lois R, da Silva Lima N, Martin M, et al.
Nat Metab
. 2022 Jul;
4(7):901-917.
PMID: 35879461
Early-life determinants are thought to be a major factor in the rapid increase of obesity. However, while maternal nutrition has been extensively studied, the effects of breastfeeding by the infant...
3.
Lugilde J, Casado S, Beiroa D, Cunarro J, Garcia-Lavandeira M, Alvarez C, et al.
Cells
. 2022 Feb;
11(3).
PMID: 35159134
Data gleaned recently shows that ghrelin, a stomach derived peptide, and liver-expressed-antimicrobial peptide 2 (LEAP-2) play opposite roles on food intake. However, the data available with LEAP-2 in relation to...
4.
Milbank E, Dragano N, Gonzalez-Garcia I, Garcia M, Rivas-Limeres V, Perdomo L, et al.
Nat Metab
. 2021 Oct;
3(10):1415-1431.
PMID: 34675439
Current pharmacological therapies for treating obesity are of limited efficacy. Genetic ablation or loss of function of AMP-activated protein kinase alpha 1 (AMPKα1) in steroidogenic factor 1 (SF1) neurons of...
5.
Gonzalez-Rellan M, Fondevila M, Fernandez U, Rodriguez A, Varela-Rey M, Veyrat-Durebex C, et al.
Nat Commun
. 2021 Aug;
12(1):5068.
PMID: 34417460
p53 regulates several signaling pathways to maintain the metabolic homeostasis of cells and modulates the cellular response to stress. Deficiency or excess of nutrients causes cellular metabolic stress, and we...
6.
Santalices I, Vazquez-Vazquez C, Santander-Ortega M, Lozano V, Araujo F, Sarmento B, et al.
Drug Deliv Transl Res
. 2021 Mar;
11(2):546.
PMID: 33742417
No abstract available.
7.
Santalices I, Vazquez-Vazquez C, Santander-Ortega M, Lozano V, Araujo F, Sarmento B, et al.
Drug Deliv Transl Res
. 2021 Feb;
11(2):524-545.
PMID: 33575972
The potential of nanoemulsions for the oral administration of peptides is still in its early stage. The aim of the present work was to rationally design, develop, and fully characterize...
8.
Presas E, Tovar S, Cunarro J, OShea J, ODriscoll C
J Pharm Sci
. 2020 Nov;
110(1):292-300.
PMID: 33152374
New therapeutic approaches have been developed during recent years for the management of diabetic patients, with glucagon-like peptides analogues (GLP-1 analogues) emerging as one of the most useful therapies. However,...
9.
Cunarro J, Buque X, Casado S, Lugilde J, Vidal A, Mora A, et al.
Mol Nutr Food Res
. 2018 Nov;
63(2):e1801096.
PMID: 30383332
Scope: The tumor suppressor p107, a pocket protein member of the retinoblastoma susceptibility protein family, plays an important role in the cell cycle and cellular adipocyte differentiation. Nonetheless, the mechanism...
10.
Sanchez-Rebordelo E, Cunarro J, Perez-Sieira S, Seoane L, Dieguez C, Nogueiras R, et al.
Int J Mol Sci
. 2018 Sep;
19(10).
PMID: 30257454
Chemerin (also known as tazarotene-induced gene 2 and retinoic acid receptor responder 2) has been identified as an adipokine that exerts effects on many biological processes, including adipogenesis, angiogenesis, inflammation,...